# Rovi

Source: https://onco.cc/companies/rovi/  
OnCo record `rovi` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Rovi is a Madrid pharmaceutical group known for low-molecular-weight heparins and long-acting injectables; its bemiparin trials in cancer-associated thrombosis are why it appears among phase 3 cancer sponsors.

## Summary

Laboratorios Farmacéuticos Rovi, founded in 1946 in Madrid and listed on the Spanish stock exchange, makes the low-molecular-weight heparin bemiparin, contract-manufactures injectables and develops long-acting formulations. Its phase 3 trials of bemiparin for preventing and treating venous thromboembolism in cancer patients are registered on ClinicalTrials.gov under Rovi as lead sponsor.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: Laboratorios Farmacéuticos Rovi; Rovi Pharmaceuticals Laboratories; Laboratorios Rovi
- Tags: ctgov-sponsor
- HQ: Madrid
- Type: pharma
- Website: https://www.rovi.es

## Sources

- Official website: https://www.rovi.es
- ClinicalTrials.gov: trials led by Laboratorios Farmacéuticos Rovi: https://clinicaltrials.gov/search?lead=Laboratorios%20Farmac%C3%A9uticos%20Rovi
- Wikidata: https://www.wikidata.org/wiki/Q65180652

## Connected records

- fronts: [Supportive Care & Survivorship](https://onco.cc/fronts/supportive-care/)
- technologies: [Cancer-associated thrombosis prevention and treatment](https://onco.cc/technologies/cancer-associated-thrombosis/)
- terms: [Clinical trial](https://onco.cc/terms/clinical-trial/), [Pivotal (registrational) trial](https://onco.cc/terms/pivotal-trial/)

---
JSON: https://onco.cc/api/v1/entities/rovi.json